Recent News for ORGS - Orgenesis Inc.

Date Title
Mar 29 Orgenesis Enters into Collaboration Agreement with the Bambino Gesù Children's Hospital in Rome to Establish Point of Care Cell and Gene Therapy Center
Mar 18 HEXO, CSIQ, LAZR and SIG among premarket gainers
Mar 18 Orgenesis collaborates with MIDA to establish point-of-care centers at hospitals and medical institutions
Mar 18 Orgenesis Enters into Collaboration Agreement with MIDA to Deploy OMPULs for Point-of-Care Research and Development of Promising Cell and Gene Therapies
Mar 11 Orgenesis updates on Celyvir therapy collaboration deal
Mar 11 Orgenesis Enters Second Phase of Collaboration with Hospital Infantil Universitario Niño Jesús in Madrid with Exclusive License to Commercialize Celyvir Solid Tumor Therapy
Mar 9 Orgenesis. (ORGS) CEO Vered Caplan on Q4 2020 Results - Earnings Call Transcript
Mar 9 The Daily Biotech Pulse: Regulatory Setback For Acadia, Lilly Forges Diabetes Antibody Treatment Collaboration, Aytu's Positive COVID-19 Data
Mar 9 Orgenesis reports FY results
Mar 9 Orgenesis Provides Fiscal 2020 Year-End Results and Corporate Update; Expands POCare Therapeutic Pipeline, POCare Technologies, and POCare Network
Mar 9 Earnings Scheduled For March 9, 2021
Mar 8 Orgenesis and Cure Therapeutics partner to commercialize gene therapies for cancer treatment
Mar 8 Orgenesis Mobile Processing Units and Labs (OMPULs) to be Used for Point-of-Care Production and Commercialization of Cell and Gene Therapies in Collaboration with Dong-a University Hospital and Cure Therapeutics in South Korea
Mar 4 Orgenesis Schedules Fiscal 2020 Year-End Business Update Conference Call
Feb 16 Orgenesis to Present Today at the Winter Wonderland Conference-Best Ideas from the Buy-Side
Jan 28 Orgenesis: A Cell And Gene Therapy Disruptor With A Nice Risk Reward Profile
Jan 25 Is Orgenesis (NASDAQ:ORGS) Using Debt In A Risky Way?
Nov 6 Orgenesis reports Q3 results
Nov 5 Orgenesis Third Quarter 2020 Revenue Increases 40% Reflecting Continued Progress of POCare Platform
Nov 3 Orgenesis Announces Virtual 2020 Annual Meeting of Stockholders
Oct 26 Did Orgenesis' (NASDAQ:ORGS) Share Price Deserve to Gain 44%?
Oct 19 Orgenesis Completes Acquisition of Koligo Therapeutics and Announces Additional Acquisition of Icellator® Technology from Tissue Genesis in Related Transaction
Back to the Main ORGS Page...